IMVT

Immunovant, Inc.

Healthcare · Biotechnology

$56.24 sample

-0.77 (-1.35%) 1D

Market cap

$152.6B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-04

Alerts

8

Price$56.24 +6.15% 3M daily closessample

58.9151.52

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: EVP, Operations
Sep 22INSInsider buy: 10% owner
Sep 11INSInsider sell: Chief Executive Officer
Sep 04SEC8-K filed: material event
Aug 28INSInsider sell: EVP, Operations
Aug 25INSInsider sell: General Counsel
Aug 19INSInsider sell: Chief Executive Officer
Aug 13INSInsider buy: General Counsel

Sign up to see the real IMVT record →

Company facts

SEC EDGAR registration

Name: Immunovant, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -48sample, -100 to +100
Reporting currency: USD

Who is positioning in IMVT

sample

Insiders: 33 insider transactions over 90 days, net selling, $751.3M
Congress: 5 members traded over 90 days
Institutions · 13F: 17 funds hold $858.9M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.4B +20.8% y/y

Q4 2024Q3 2026

Inventory$6.1B +13.1% y/y

Q4 2024Q3 2026

Accounts receivable$4.3B +4.4% y/y

Q4 2024Q3 2026

Total debt$11.5B +10.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $87.8B -3.9% 3M
Sample peer B: $56.1B -9.4% 3M
Sample peer C: $146.2B -0.9% 3M
Sample peer D: $54.5B +13.1% 3M
Sample peer E: $151.4B +7.4% 3M